Poland· PL-100205897
PoltechRBC
A 99mtc-technetium-zinn markierte zellen product containing stanni pyrophosphatis et technetii (99mtc) solutio iniectabilis, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-zinn markierte zellen is registered in 8 of 19 countries.
Countries holding a registration under ATC V09GA06 (99mtc-technetium-zinn markierte zellen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
99mtc-technetium-zinn markierte zellen · ATC V09GA06
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Stanni pyrophosphatis et technetii (99mTc) solutio iniectabilis
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09GA06
- ATC class
- 99mTc-Technetium-Zinn markierte Zellen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990344116
- gtin05909990344123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09GA06
99mtc-technetium-zinn markierte zellen, as other registers publish it.
- FinlandAngiocisCIS bio international
- BelgiumAngiocis 20 mgCis Bio International
- FinlandMediam Stannous AgentMediam
- DenmarkTechneScan PYPCurium Netherlands B.V.
- CzechiaTECHNESCAN PYPCurium Netherlands B.V., Petten
- BelgiumTechneScan PYP 20 mgCurium Belgium
- IrelandTechnescan PYP 20 mg kit for radiopharmaceutical preparationCurium Netherlands B.V.
- NetherlandsTechnescan PYP, 20 mg kit voor radiofarmaceutisch preparaatCurium Netherlands B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd0a4654-3551-42f9-b377-4252f5d09aab GET /v1/drugs/dd0a4654-3551-42f9-b377-4252f5d09aab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Liofilizat do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "13,4 mg",
"packaging": "Lz ¦ Skasowane ¦ 1506\n1 fiol. \n05909990344116 ¦ Lz ¦ 54626\n3 fiol. 10 ml\n05909990344123 ¦ Lz ¦ 54627\n6 fiol. 10 ml",
"substance": "Natrii pyrophosphas decahydricus 13.4 mg",
"common_name": "Stanni pyrophosphatis et technetii (99mTc) solutio iniectabilis",
"pl_product_id": "100205897",
"pozwolenie_nr": "03441",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about 99mtc-technetium-zinn markierte zellen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.